Supplementary Tables: Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19
datasetposted on 2022-02-10, 10:29 authored by Serdar Can Güven, Hakan Apaydın, Bahar Özdemir, Berkan Armağan, İhsan Ateş, Abdulsamet Erden, Orhan Küçükşahin, Ahmet Omma
Supplementary Table 1. ANCA status and reasons for ANCA testing in patients.
Supplementary Table 2. Comparison of factors that can be associated with mortality between ANCA negative and ANCA positive patients with mortality.
Supplementary Table 3. Distribution of treatment agents used for COVID-19 in patients.